Publications

5439 Results

Three- and seven- month prostate-specific antigen levels as prognostic markers for overall survival in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel or bicalutamide

Authors
M Parikh;C Tangen;M Hussain;S Gupta;Y Jo;S Callis;A Harzstark;C Paller;S George;M Zibelman;H Cheng;B Maughan;J Zhang;R Pachynski;A Bryce;D Lin;D Quinn;I Thompson;SP Lerner;T Dorff;P Lara;N Agarwal
Journal / Conference
European Urology Oncology Mar 23:S2588-9311(24)00054-3. doi: 10.1016/j.euo.2024.03.001. Online ahead of print
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID38523017
Study Number(s)
S1216

SWOG S1820: A Pilot Randomized Trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer (AIMS-RC)

Authors
V Sun;KA Guthrie;T Crane;K Arnold;S Colby;S Freylersythe;C Braun-Inglis;R Topacio;C Messick;J Carmichael;A Muskovitz;M Nashawaty;M Bajaj;S Cohen;D Flaherty;M O'Rourke;L Jones;R Krouse;C Thomson
Journal / Conference
Cancer Feb 22. doi: 10.1002/cncr.35264. Online ahead of print
Year
2024
Research Committee(s)
Palliative and End of Life Care
PMID
PMID38386696
Study Number(s)
S1820

Analysis of immune-related genes (IRGs) and their potential role in sexual dimorphism in metastatic colorectal cancer (mCRC) patients (pts)

Authors
P Mittal;Y Yang;S Soni;F Battaglin;J Millstein;S Stintzing;A Parikh;J Lo;L Torres-Gonzalez;S Algaze;P Jayachandran;K Ashouri;A Wong;W Zhang;C Mancao;C Cremolini;V Heinemann;I Singh;H-J Lenz
Journal / Conference
ASCO GI Cancers Symposium (January 18-20, 2024, San Francisco, CA), poster; J Clin Oncol 42, 2024 (suppl 3; abstr 182)
Year
2024
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

North American Patterns of Care in Clinical Stage I Testicular Cancer. Secondary Data Use Project for SWOG S1823

Authors
A Morin Coulombe;S Colby;J King;M Neuhouser;B Arun;S Daneshman;A Harzstark;K Arnold;C Nichols;L Nappi
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), poster; J Clin Oncol 42, 2024 (suppl 4; abstr 509)
Year
2024
Research Committee(s)
Prevention and Epidemiology
Study Number(s)
S1823

Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL

Authors
J Wolfson;A Grimes;M Nuno;C Kerber;S Ramakrishnan;M Beauchemin;D Dickens;J Levine;M Roth;M Scialla;W Woods;S Vargas;K Boayue;G Chang;W Stock;D Hershman;E Curran;A Advani;K O'Dwyer;S Luger;J Liu;D Freyer;L Sung;S Parsons
Journal / Conference
JCO Oncology Practice Apr;20(4):491-502
Year
2024
Research Committee(s)
Cancer Care Delivery

SWOG S2303: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS = 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)

Authors
A Saeed;S Colby;P Oberstein;D Duda;R Agarwal;C Figeroa-Moseley;R Vaidya;J Unger;K Guthrie;F Rocha;M Senthil;R Safyan;Z Wainberg;S Iqbal;EG Chiorean;PA Philip
Journal / Conference
J Clin Oncol 42, 2024 (suppl 3; abstr TPS430); ASCO GI Cancers Symposium (January 18-20, 2024, San Francisco, CA), TIP, poster
Year
2024
Research Committee(s)
Gastrointestinal

Improved outcomes with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data

Authors
M Othus;G Garcia-Manero;J Godwin;J Weick;F Appelbaum;H Erba;E Estey
Journal / Conference
Haematologica Jan 1;108(1):42-47
Year
2023
Research Committee(s)
Leukemia
PMID
PMID35833298
PMC
PMC9827148
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031

Relevance of bone marrow biopsies for response assessment in U.S. National Cancer Institute National Clinical Trials Network follicular lymphoma clinical trials

Authors
S Rutherford;J Yin;L Pederson;G Perez Burbano;P LaPlant;M Shadman;H Li;M LeBlanc;V Kenkre;F Hong;K Blum;T Dockter;P Martin;S Jung;B Grant;C Rosenbaum;C Ujjani;P Barr;J Unger;B Cheson;N Bartlett;B Kahl;JW Friedberg;S Mandrekar;J Leonard
Journal / Conference
Journal of Clinical Oncology 10;41(2):336-342
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID35787017
PMC
PMC9839232
Study Number(s)
S0016, S0801

Acquired Genomic Alterations on First Line Chemotherapy with Cetuximab/Bevacizumab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of CALGB/SWOG-80405 Trial

Authors
K Raghav;F-S Ou;A Venook;F Innocenti;R Sun;H-J Lenz;ES Kopetz
Journal / Conference
Journal of Clinical Oncology Jan 20;41(3):472-478
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36067452
PMC
PMC9870237
Study Number(s)
CTSU/C80405

Phase III Prospectively Randomized Trial of Perioperative 5-FU after Curative Resection, Followed by 5-FU/Leucovorin for Patients with Colon Cancer- Intergroup: A trial of the ECOG-ACRIN Research Group (E1292)

Authors
MM Kemeny;F Zhao;A Forastiere;P Catalano;D Heimann;SR Hamilton;B Meidema;N Dawson;LM Weiner;B Smith;BA Mason;S Graziano;PB Gilman;A Venook;H Pinto;RP Whitehead;PJ O'Dwyer;AB Benson
Journal / Conference
Annals Surgical Oncology Feb;30(2):1099-1109
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36305992
PMC
PMC9807536